Edition:
United States

MacroGenics Inc (MGNX.OQ)

MGNX.OQ on NASDAQ Stock Exchange Global Select Market

21.84USD
2:21pm EDT
Change (% chg)

$-0.43 (-1.93%)
Prev Close
$22.27
Open
$22.17
Day's High
$22.24
Day's Low
$21.81
Volume
17,219
Avg. Vol
141,753
52-wk High
$32.57
52-wk Low
$14.36

Chart for

About

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology... (more)

Overall

Beta: 2.47
Market Cap(Mil.): $938.15
Shares Outstanding(Mil.): 42.20
Dividend: --
Yield (%): --

Financials

  MGNX.OQ Industry Sector
P/E (TTM): -- 217.69 33.34
EPS (TTM): -0.89 -- --
ROI: -12.02 -3.65 13.18
ROE: -13.08 -5.62 15.09

BRIEF-MacroGenics Posts Qtrly Net Loss Per Common Share Of $1.34

* MACROGENICS PROVIDES UPDATE ON CORPORATE PROGRESS AND 1ST QUARTER 2018 FINANCIAL RESULTS

May 07 2018

BRIEF-Macrogenics Inc Prices Of Public Offering

* MACROGENICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

Mar 28 2018

BRIEF-Macrogenics Announces Proposed Public Offering Of Common Stock

* MACROGENICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

Mar 26 2018

BRIEF-Macrogenics Provides Update On Corporate Progress And 2017 Financial Results

* MACROGENICS PROVIDES UPDATE ON CORPORATE PROGRESS AND 2017 FINANCIAL RESULTS

Feb 27 2018

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF233.25 -0.75
Roche Holding Ltd. (RO.S) CHF237.20 -1.40
Amgen, Inc. (AMGN.OQ) $189.98 -0.51
Xencor Inc (XNCR.OQ) $41.64 -0.69

Earnings vs. Estimates